$417M Johnson & Johnson Baby Powder Ovarian Cancer Verdict
August 22, 2017
A California jury returned its verdict on August 21, 2017 in the amount of $417 million in favor of a woman who had used Johnson & Johnson Baby Powder for decades and later developed ovarian cancer. The California jury’s verdict included $70 million in compensatory damages and an additiona[...]
Continue Reading
$17.6M Opioid Malpractice Verdict
July 26, 2017
A Missouri medical malpractice jury awarded the plaintiffs $17.6 million on June 27, 2017 after a seven-day trial in a medical malpractice case against the plaintiff’s former primary care physician who was alleged to have prescribed ever-increasing amounts of opioids for the plaintiff’s [...]
Continue Reading
First Xarelto Trial Results In Win For The Defendants
May 25, 2017
On May 3, 2017, a federal jury in Louisiana found against a Xarelto plaintiff who claimed that the defendants, Johnson & Johnson (“J & J”) and Bayer AG, had inadequately warned him regarding the internal bleeding risk associated with Xarelto, a blood-thinning medication that has [...]
Continue Reading
$3M Paxil Labeling Verdict For Suicide Death
May 9, 2017
On April 20, 2017, a Chicago jury returned its verdict in the amount of $3 million in favor of a widow whose 57-year-old husband was a corporate attorney who committed suicide while taking a generic version of Paxil, by stepping into the path of a train on July 15, 2010. The defendant was GlaxoSmith[...]
Continue Reading
Xarelto Lawsuits Allege Undisclosed Risk of Internal Bleeding
April 27, 2017
More than 18,000 patients have filed lawsuits alleging that the blood-thinning medication Xarelto caused them to suffer internal bleeding, the risk of which they allege was not disclosed to them. Johnson & Johnson and Bayer jointly developed Xarelto, which was approved by the FDA in 2011 to be u[...]
Continue Reading
Study Of Adverse Drug Events Leading To ER Visits In The U.S.
December 9, 2016
A study published in JAMA on November 22/29, 2016 estimated that the annual prevalence of emergency room visits in the United States in 2013 and 2014 for adverse drug events was 4 per 1,000 individuals, and that 27.3% of the visits resulted in hospitalization. The most common medications involve[...]
Continue Reading